Skip to main content
. 2020 Jan 13;189(3):771–776. doi: 10.1007/s11845-019-02168-4

Table 1.

Estimated European prevalence rates of the 22 selected Rare Diseases

Rare disease name Estimated prevalence (per 100,000)

Congenital isolated hyperinsulinism

Scleroderma (systemic sclerosis, localised sclerosis)

Familial QT syndrome (Inc. Romano Ward)

Primary systemic amyloidosis

Retinitis pigmentosa

Fragile X

Neurofibromatosis 1

Marfan syndrome

Sickle cell anaemia

Sarcoidosis

Haemophilia

Huntington’s disease and rare neurodegenerative disease

Phenylketonuria

22q11.2 Deletion syndrome (DiGeorge syndrome)

Duchenne or Becker muscular dystrophy

Prader-Willi syndrome

Epidermolysis bullosa

Mucopolysaccharidosis (type 2)

Rare ataxias (including Friedreich’s)

Tuberous sclerosis

Osteogenesis imperfecta

Motor neuron disease

2.0 BP

42.0 P

40.0 BP

30.0 P

26.7 P

32.5 P

21.3 P

15.0 P

22.0 P

12.5 P

7.7 P

2.7 P

10.0 BP

37.5 BP

4.78 P/ 1.53 P

3.1 BP

2.2 BP *

10.0 P

2.0 P *

12.0 P

10.0 P

3.85 P

Estimates provided from the Orphanet Report Series

P = prevalence; BP = birth prevalence

*Estimates shown are for epidermolysis bullosa simplex and Friedreich’s Ataxia